Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Hans-Jürgen Möller, Koen Demyttenaere, Bengt Olausson, Johan Szamosi, Ellis Wilson, David Hosford, Geoffrey Dunbar, Raj Tummala & Hans Eriksson. (2015) Two Phase III randomised double-blind studies of fixed-dose TC-5214 (dexmecamylamine) adjunct to ongoing antidepressant therapy in patients with major depressive disorder and an inadequate response to prior antidepressant therapy. The World Journal of Biological Psychiatry 16:7, pages 483-501.
Read now
Read now
Narong Maneeton, Benchalak Maneeton, Kanokkwan Eurviriyanukul & Manit Srisurapanont. (2013) Efficacy, tolerability, and acceptability of bupropion for major depressive disorder: a meta-analysis of randomized–controlled trials comparison with venlafaxine. Drug Design, Development and Therapy 7, pages 1053-1062.
Read now
Read now
Sheng-Min Wang & Chi-Un Pae. (2013) How much to worry about the FDA warning in the use of citalopram?. Expert Review of Neurotherapeutics 13:8, pages 883-886.
Read now
Read now
Alessandro Serretti, Paolo Olgiati, Emanuele Bajo, Marco Bigelli & Diana De Ronchi. (2011) A model to incorporate genetic testing (5-HTTLPR) in pharmacological treatment of major depressive disorders. The World Journal of Biological Psychiatry 12:7, pages 501-515.
Read now
Read now
Articles from other publishers (23)
Xufei Luo, Di Zhu, Jitao Li, Mengjuan Ren, Yunlan Liu, Tianmei Si & Yaolong Chen. (2023) Selection of the optimal dose of sertraline for depression: A dose-response meta-analysis of randomized controlled trials. Psychiatry Research 327, pages 115391.
Crossref
Crossref
Chris F Johnson, Margaret Maxwell, Brian Williams, Nadine Dougall & Stephen MacGillivray. (2022) Dose-response effects of selective serotonin reuptake inhibitor monotherapy for the treatment of depression: systematic review of reviews and meta-narrative synthesis. BMJ Medicine 1:1, pages e000017.
Crossref
Crossref
Luca Sforzini, Courtney Worrell, Melisa Kose, Ian M. Anderson, Bruno Aouizerate, Volker Arolt, Michael Bauer, Bernhard T. Baune, Pierre Blier, Anthony J. Cleare, Philip J. Cowen, Timothy G. Dinan, Andrea Fagiolini, I. Nicol Ferrier, Ulrich Hegerl, Andrew D. Krystal, Marion Leboyer, R. Hamish McAllister-Williams, Roger S. McIntyre, Andreas Meyer-Lindenberg, Andrew H. Miller, Charles B. Nemeroff, Claus Normann, David Nutt, Stefano Pallanti, Luca Pani, Brenda W. J. H. Penninx, Alan F. Schatzberg, Richard C. Shelton, Lakshmi N. Yatham, Allan H. Young, Roland Zahn, Georgios Aislaitner, Florence Butlen-Ducuing, Christine Fletcher, Marion Haberkamp, Thomas Laughren, Fanni-Laura Mäntylä, Koen Schruers, Andrew Thomson, Gara Arteaga-Henríquez, Francesco Benedetti, Lucinda Cash-Gibson, Woo Ri Chae, Heidi De Smedt, Stefan M. Gold, Witte J. G. Hoogendijk, Valeria Jordán Mondragón, Eduard Maron, Jadwiga Martynowicz, Elisa Melloni, Christian Otte, Gabriela Perez-Fuentes, Sara Poletti, Mark E. Schmidt, Edwin van de Ketterij, Katherine Woo, Yanina Flossbach, J. Antoni Ramos-Quiroga, Adam J. Savitz & Carmine M. Pariante. (2021) A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trials. Molecular Psychiatry 27:3, pages 1286-1299.
Crossref
Crossref
O'Mareen Spence, Gloria Reeves & Susan dosReis. (2021) Evaluating the association between antidepressant dose trajectories and treatment augmentation in pediatric depression. Pharmacoepidemiology and Drug Safety 31:2, pages 176-186.
Crossref
Crossref
Alexander Lisinski, Fredrik Hieronymus, Elias Eriksson & Susanna M. Wallerstedt. (2021) Low SSRI dosing in clinical practice—a register‐based longitudinal study. Acta Psychiatrica Scandinavica 143:5, pages 434-443.
Crossref
Crossref
Gerard J. Marek, Stephen Chaney & Mark J. Benvenga. 2019. Antidepressants - Preclinical, Clinical and Translational Aspects. Antidepressants - Preclinical, Clinical and Translational Aspects.
Fredrik Hieronymus. (2019) Which antidepressant doses are optimal?. The Lancet Psychiatry 6:7, pages 552-554.
Crossref
Crossref
Daniel J. Safer. (2016) Raising the Minimum Effective Dose of Serotonin Reuptake Inhibitor Antidepressants. Journal of Clinical Psychopharmacology 36:5, pages 483-491.
Crossref
Crossref
F Hieronymus, S Nilsson & E Eriksson. (2016) A mega-analysis of fixed-dose trials reveals dose-dependency and a rapid onset of action for the antidepressant effect of three selective serotonin reuptake inhibitors. Translational Psychiatry 6:6, pages e834-e834.
Crossref
Crossref
Anjali L. Varigonda, Ewgeni Jakubovski, Matthew J. Taylor, Nick Freemantle, Catherine Coughlin & Michael H. Bloch. (2015) Systematic Review and Meta-Analysis: Early Treatment Responses of Selective Serotonin Reuptake Inhibitors in Pediatric Major Depressive Disorder. Journal of the American Academy of Child & Adolescent Psychiatry 54:7, pages 557-564.
Crossref
Crossref
Anthony Cleare, CM Pariante, AH Young, IM Anderson, D Christmas, PJ Cowen, C Dickens, IN Ferrier, J Geddes, S Gilbody, PM Haddad, C Katona, G Lewis, A Malizia, RH McAllister-Williams, P Ramchandani, J Scott, D Taylor & R Uher. (2015) Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines. Journal of Psychopharmacology 29:5, pages 459-525.
Crossref
Crossref
Bruria HirshRokach, Galia Spectre, Ela Shai, Amit Lotan, Amit Ritter, Fadiea Al-Aieshy, Rickard E. Malmström, David Varon & Ronny Alcalai. (2015) Differential Impact of Selective Serotonin Reuptake Inhibitors on Platelet Response to Clopidogrel: A Randomized, Double-Blind, Crossover Trial. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 35:2, pages 140-147.
Crossref
Crossref
Arndis Simonsen, Jørgen Scheel-Krüger, Mads Jensen, Andreas Roepstorff, Arne Møller, Chris D Frith & Daniel Campbell-Meiklejohn. (2014) Serotoninergic effects on judgments and social learning of trustworthiness. Psychopharmacology 231:14, pages 2759-2769.
Crossref
Crossref
G. Xu, H.-W. Jiang, J. Fang, H. Wen, B. Gu, J. Liu, L.-M. Zhang, Q. Ding & Y.-F. Zhang. (2014) An improved dosage regimen of sertraline hydrochloride in the treatment for premature ejaculation: an 8-week, single-blind, randomized controlled study followed by a 4-week, open-label extension study. Journal of Clinical Pharmacy and Therapeutics 39:1, pages 84-90.
Crossref
Crossref
Frederick Rohan Walker. (2013) A critical review of the mechanism of action for the selective serotonin reuptake inhibitors: Do these drugs possess anti-inflammatory properties and how relevant is this in the treatment of depression?. Neuropharmacology 67, pages 304-317.
Crossref
Crossref
Ross J. BaldessariniRoss J. Baldessarini. 2013. Chemotherapy in Psychiatry. Chemotherapy in Psychiatry
155
250
.
Narong Maneeton, Benchalak Maneeton, Manit Srisurapanont & Stephen D Martin. (2012) Quetiapine monotherapy in acute phase for major depressive disorder: a meta-analysis of randomized, placebo-controlled trials. BMC Psychiatry 12:1.
Crossref
Crossref
Rif S. El-Mallakh & Brian Briscoe. (2012) Studies of Long-Term Use of Antidepressants. CNS Drugs 26:2, pages 97-109.
Crossref
Crossref
H.-J. Möller, I. Bitter, J. Bobes, K. Fountoulakis, C. Höschl & S. Kasper. (2020) Position statement of the European Psychiatric Association (EPA) on the value of antidepressants in the treatment of unipolar depression. European Psychiatry 27:2, pages 114-128.
Crossref
Crossref
Ian M. Anderson. 2013. Behavioral Neurobiology of Depression and Its Treatment. Behavioral Neurobiology of Depression and Its Treatment
263
289
.
Alan G Wade, Gordon M Crawford & Ann Yellowlees. (2011) Efficacy, safety and tolerability of escitalopram in doses up to 50 mg in Major Depressive Disorder (MDD): an open-label, pilot study. BMC Psychiatry 11:1.
Crossref
Crossref
Louis F. Fabre, Louis C. Smith & Leonard R. DeRogatis. (2011) Gepirone‐ER Treatment of Low Sexual Desire Associated with Depression in Women as Measured by the DeRogatis Inventory of Sexual Function (DISF) Fantasy/Cognition (Desire) Domain—A Post Hoc Analysis. The Journal of Sexual Medicine 8:9, pages 2569-2581.
Crossref
Crossref
Louis F. Fabre, Candace S. Brown, Louis C. Smith & Leonard R. DeRogatis. (2011) Gepirone-ER Treatment of Hypoactive Sexual Desire Disorder (HSDD) Associated with Depression in Women. The Journal of Sexual Medicine 8:5, pages 1411-1419.
Crossref
Crossref